Search Within

Michael Scordo

Formats
  1. Meeting Abstract (250)
  2. Journal Article (104)
  3. Research Letter (15)
  4. Correspondence (7)
  5. Editorial (5)
  6. Review (4)
  7. Book Section (1)
  8. Guidelines (1)
Groups
  1. Bone Marrow Transplant (387)
  2. CTCR Scholars (387)
  3. Center for Hematologic Malignancies (387)
  4. Department of Medicine (387)
  5. Hematologic Malignancies, Division of (387)
  6. Survivorship Research (338)

More Groups

People
  1. Gunjan Shah (298)
  2. Sergio Giralt (278)
  3. Miguel-Angel Perales (177)
  4. Sean Devlin (152)
  5. Heather Landau (141)
  6. Parastoo Dahi (140)

More People

Years
  1. 2025 (22)
  2. 2024 (72)
  3. 2023 (81)
  4. 2022 (49)
  5. 2021 (27)
  6. 2020 (53)

More Years

Publications
  1. Blood (123)
  2. Biology of Blood and Marrow Transplantation (56)
  3. Clinical Lymphoma, Myeloma and Leukemia (36)
  4. Bone Marrow Transplantation (26)
  5. Blood Advances (21)
  6. Transplantation and Cellular Therapy (15)

More Publications

Publishers
  1. American Society of Hematology (144)
  2. Elsevier Inc. (122)
  3. Nature Publishing Group (40)
  4. American Society of Clinical Oncology (14)
  5. Wiley Blackwell (9)
  6. Oxford University Press (7)

More Publishers

Results (387)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Patients with central nervous system lymphoma undergoing thiotepa, busulfan, and cyclophosphamide-conditioned autologous stem cell transplantation are at a higher risk for DNA virus infections than patients with systemic non-Hodgkin lymphoma receiving traditional conditioning
    Meeting Abstract

    Scordo, M.; Morjaria, S. M.; Bhatia, A.; Littmann, E. R.; Maloy, M.; DeAngelis, L.; Giralt, S. A.; Taur, Y.; Sauter, C. S.
    Blood (2017)

    Fulltext@MSK | Save
  • More intensive fludarabine/busulfan (Flu/Bu) conditioning regimens result in similar outcomes without adding serious toxicity when compared to fludarabine/melphalan (Flu/Mel) in patients undergoing allogeneic hematopoietic cell transplant (Allo-HCT)
    Meeting Abstract

    Pappacena, J.; Bhatt, V.; Shah, G. L.; Hilden, P.; Maloy, M.; Buie, L. W.; Giralt, S. A.; Scordo, M.
    Blood (2017)

    Fulltext@MSK | Save
  • The impact of toxicities on first-year outcomes after ex vivo CD34(+)-selected allogeneic hematopoietic cell transplantation in adults with hematologic malignancies
    Journal Article

    Kosuri, S.; Herrera, D. A.; Scordo, M.; Shah, G. L.; Cho, C.; Devlin, S. M.; Maloy, M. A.; Nieves, J.; Borrill, T.; Carlow, D. C.; more...
    Biology of Blood and Marrow Transplantation (2017)

    Fulltext@MSK | Save
  • A comprehensive assessment of toxicities in patients with central nervous system lymphoma undergoing autologous stem cell transplantation using thiotepa, busulfan, and cyclophosphamide conditioning
    Journal Article

    Scordo, M.; Bhatt, V.; Hsu, M.; Omuro, A. M.; Matasar, M. J.; DeAngelis, L. M.; Dahi, P. B.; Moskowitz, C. H.; Giralt, S. A.; Sauter, C. S.
    Biology of Blood and Marrow Transplantation (2017)

    Fulltext@MSK | Save
  • Comparable survival and incidence of toxicity for older adult patients after CD34+ selected allogeneic hematopoietic stem cell transplantation
    Meeting Abstract

    Shah, G. L.; Scordo, M.; Kosuri, S.; Herrera, D. A.; Maloy, M. A.; Nieves, J.; Devlin, S.; Borrill, T.; Avecilla, S. T.; Meagher, R. C.; more...
    Blood (2016)

    Fulltext@MSK | Save
  • A comprehensive analysis of late toxicities and associated risk factors in long-term survivors of myeloablative conditioned allogeneic hematopoietic cell transplantation using ex-vivo CD34+ selection-based graft-versus-host disease prophylaxis
    Meeting Abstract

    Scordo, M.; Shah, G. L.; Kosuri, S.; Herrera, D. A.; Devlin, S.; Maloy, M. A.; Nieves, J.; Borrill, T.; Avecilla, S. T.; Meagher, R. C.; more...
    Blood (2016)

    Fulltext@MSK | Save
  • Toxoplasma encephalitis in atypical hosts at an academic cancer center
    Journal Article

    Morjaria, S.; Epstein, D. J.; Romero, F. A.; Taur, Y.; Seo, S. K.; Papanicolaou, G. A.; Hatzoglou, V.; Rosenblum, M.; Perales, M. A.; Scordo, M.; more...
    Open Forum Infectious Diseases (2016)

    Fulltext@MSK | Save
  • Acute toxicities in patients receiving ex-vivo CD34+ selected allogeneic stem cell transplantation for hematologic malignancies
    Meeting Abstract

    Herrera, D.; Perales, M. A.; Shah, G.; Scordo, M.; Devlin, S.; Maloy, M.; Nieves, J.; Avecilla, S.; Meagher, R.; Gyurkocza, B.; more...
    Bone Marrow Transplantation (2016)

    Fulltext@MSK | Save
  • Toxicities in older adult patients undergoing CD34+ selected allogeneic hematopoietic stem cell transplantation (allo-HCT)
    Meeting Abstract

    Shah, G. L.; Scordo, M.; Kosuri, S.; Herrera, D. A.; Maloy, M.; Nieves, J. L.; Devlin, S.; Avecilla, S. T.; Meagher, R.; Shaffer, B.; more...
    Bone Marrow Transplantation (2016)

    Fulltext@MSK | Save
  • Late toxicities in long-term survivors of adult allogeneic hematopoietic cell transplantation (allo-HCT) using ex-vivo CD34+ selection-based graft-versus-host disease (GVHD) prophylaxis
    Meeting Abstract

    Scordo, M.; Shah, G. L.; Devlin, S.; Maloy, M.; Kosuri, S.; Herrera, D. A.; Nieves, J.; Avecilla, S. T.; Meagher, R. C.; Gyurkocza, B.; more...
    Bone Marrow Transplantation (2016)

    Fulltext@MSK | Save